ADBiotech Co., Ltd. (KOSDAQ:179530)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,835.00
+5.00 (0.27%)
At close: Jan 23, 2026
-4.08%
Market Cap33.36B +74.2%
Revenue (ttm)14.57B +65.6%
Net Income-11.02B
EPS-1,029.38
Shares Out19.68M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume133,894
Average Volume261,048
Open1,831.00
Previous Close1,830.00
Day's Range1,760.00 - 1,874.00
52-Week Range1,351.00 - 5,450.00
Beta1.37
RSI33.13
Earnings DateMar 20, 2026

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 179530
Full Company Profile

Financial Performance

In 2024, ADBiotech's revenue was 11.14 billion, an increase of 6.34% compared to the previous year's 10.47 billion. Losses were -7.95 billion, 177.7% more than in 2023.

Financial Statements